🇺🇸 FDA
Patent

US 11590089

Beta-2 selective adrenergic receptor agonists

granted A61KA61K31/13A61K31/16

Quick answer

US patent 11590089 (Beta-2 selective adrenergic receptor agonists) held by The Regents of the University of California expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/13, A61K31/16, A61K31/337, A61K31/695